Melatonin mitigates ferroptosis and neuronal damage in ischemic stroke models, an effect achieved through the MDM2-mediated ubiquitination and degradation of ACSL4, leading to a reduction in ferroptosis markers like intracellular Fe2+ (Yu, 2024; Ji et al., 2024). Here, ACSL4 is linked to ischemic stroke.